AiCuris Anti-infective Cures reports positive phase I trial results of pritelivir for cold sores

German-based drug-development company AiCuris Anti-infective Cures has reported positive results from its phase I trial of pritelivir for the topical treatment of recurrent labial herpes (cold sores).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news